|
1
|
Sun J, Zhang C, Bao YL, Wu Y, Chen ZL, Yu
CL, Huang YX, Sun Y, Zheng LH, Wang X, et al: Parthenolide-induced
apoptosis, autophagy and suppression of proliferation in HepG2
cells. Asian Pac J Cancer Prev. 15:4897–4902. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carlisi D, D'Anneo A, Martinez R, Emanuele
S, Buttitta G, Di Fiore R, Vento R, Tesoriere G and Lauricella M:
The oxygen radicals involved in the toxicity induced by
parthenolide in MDA-MB-231 cells. Oncol Rep. 32:167–172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Fatlawi AA, Al-Fatlawi AA, Irshad M,
Rahisuddin and Ahmad A: Effect of parthenolide on growth and
apoptosis regulatory genes of human cancer cell lines. Pharm Biol.
53:104–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu C, Wang W, Jia Y, Liu X, Tong Z and Li
B: Inhibition of AMPK/autophagy potentiates parthenolide-induced
apoptosis in human breast cancer cells. J Cell Biochem.
115:1458–1466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu HJ, Jung JY, Jeong JH, Cho SD and Lee
JS: Induction of apoptosis by parthenolide in human oral cancer
cell lines and tumor xenografts. Oral Oncol. 51:602–609. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang
J, Perry SR, Labrot ES, Wu X, Lis R, et al: SMAD4-dependent barrier
constrains prostate cancer growth and metastatic progression.
Nature. 470:269–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen C, Sun MZ, Liu S, Yeh D, Yu L, Song
Y, Gong L, Hao L, Hu J and Shao S: Smad4 mediates malignant
behaviors of human ovarian carcinoma cell through the effect on
expressions of E-cadherin, plasminogen activator inhibitor-1 and
VEGF. BMB Rep. 43:554–560. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inamoto S, Itatani Y, Yamamoto T,
Minamiguchi S, Hirai H, Iwamoto M, Hasegawa S, Taketo MM, Sakai Y
and Kawada K: Loss of SMAD4 promotes colorectal cancer progression
by accumulation of myeloid-derived suppressor cells through the
CCL15-CCR1 chemokine axis. Clin Cancer Res. 22:492–501. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nikolic A, Ristanovic M, Zivaljevic V,
Rankov AD, Radojkovic D and Paunovic I: SMAD4 gene promoter
mutations in patients with thyroid tumors. Exp Mol Pathol.
99:100–103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boulay JL, Mild G, Lowy A, Reuter J,
Lagrange M, Terracciano L, Laffer U, Herrmann R and Rochlitz C:
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy
in patients with colorectal cancer. Br J Cancer. 87:630–634. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Papageorgis P, Cheng K, Ozturk S, Gong Y,
Lambert AW, Abdolmaleky HM, Zhou JR and Thiagalingam S: Smad4
inactivation promotes malignancy and drug resistance of colon
cancer. Cancer Res. 71:998–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SL, Liu YC, Seo SY, Kim SH, Kim IH,
Lee SO, Lee ST, Kim DG and Kim SW: Parthenolide induces apoptosis
in colitis-associated colon cancer, inhibiting NF-κB signaling.
Oncol Lett. 9:2135–2142. 2015.PubMed/NCBI
|
|
13
|
Zhao X, Liu X and Su L: Parthenolide
induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung
cancer cells. J Exp Clin Cancer Res. 33:32014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ghantous A, Saikali M, Rau T,
Gali-Muhtasib H, Schneider-Stock R and Darwiche N: Inhibition of
tumor promotion by parthenolide: Epigenetic modulation of
p21. Cancer Prev Res. 5:1298–1309. 2012. View Article : Google Scholar
|
|
15
|
Li CJ, Guo SF and Shi TM: Culture
supernatants of breast cancer cell line MDA-MB-231 treated with
parthenolide inhibit the proliferation, migration, and lumen
formation capacity of human umbilical vein endothelial cells. Chin
Med J. 125:2195–2199. 2012.PubMed/NCBI
|
|
16
|
Sohma I, Fujiwara Y, Sugita Y, Yoshioka A,
Shirakawa M, Moon JH, Takiguchi S, Miyata H, Yamasaki M, Mori M, et
al: Parthenolide, an NF-κB inhibitor, suppresses tumor growth and
enhances response to chemotherapy in gastric cancer. Cancer
Genomics Proteomics. 8:39–47. 2011.PubMed/NCBI
|
|
17
|
Xin Y, Yin F, Qi S, Shen L, Xu Y, Luo L,
Lan L and Yin Z: Parthenolide reverses doxorubicin resistance in
human lung carcinoma A549 cells by attenuating NF-κB activation and
HSP70 up-regulation. Toxicol Lett. 221:73–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu D, Liu Y, Liu M, Ran L and Li Y:
Reversing resistance of multidrug-resistant hepatic carcinoma cells
with parthenolide. Future Oncol. 9:595–604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ramachandra M, Atencio I, Rahman A,
Vaillancourt M, Zou A, Avanzini J, Wills K, Bookstein R and Shabram
P: Restoration of transforming growth factor Beta signaling by
functional expression of smad4 induces anoikis. Cancer Res.
62:6045–6051. 2002.PubMed/NCBI
|
|
20
|
Li X, Liu B, Xiao J, Yuan Y, Ma J and
Zhang Y: Roles of VEGF-C and Smad4 in the lymphangiogenesis,
lymphatic metastasis, and prognosis in colon cancer. J Gastrointest
Surg. 15:2001–2010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bierie B and Moses HL: Tumour
microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Nat Rev Cancer. 6:506–520. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kozak MM, von Eyben R, Pai J, Vossler SR,
Limaye M, Jayachandran P, Anderson EM, Shaffer JL, Longacre T, Pai
RK, et al: Smad4 inactivation predicts for worse prognosis and
response to fluorouracil-based treatment in colorectal cancer. J
Clin Pathol. 68:341–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alhopuro P, Alazzouzi H, Sammalkorpi H,
Dávalos V, Salovaara R, Hemminki A, Järvinen H, Mecklin JP,
Schwartz S Jr, Aaltonen LA, et al: SMAD4 levels and response to
5-fluorouracil in colorectal cancer. Clin Cancer Res. 11:6311–6316.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang B, Leng C, Wu C, Zhang Z, Dou L, Luo
X, Zhang B and Chen X: Smad4 sensitizes colorectal cancer to
5-fluorouracil through cell cycle arrest by inhibiting the
PI3K/Akt/CDC2/survivin cascade. Oncol Rep. 35:1807–1815. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu SL, Lee DC, Son JW, Park CG, Lee HY and
Kang J: Histone deacetylase 4 mediates SMAD family member 4
deacetylation and induces 5-fluorouracil resistance in breast
cancer cells. Oncol Rep. 30:1293–1300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abdallah HM, Al-Abd AM, El-Dine RS and
El-Halawany AM: P-glycoprotein inhibitors of natural origin as
potential tumor chemo-sensitizers: A review. J Adv Res. 6:45–62.
2015. View Article : Google Scholar : PubMed/NCBI
|
